The de novo design and synthesis of cyclic urea inhibitors of factor Xa: optimization of the S4 ligand
Authors:
- Robert A. GalemmoRGRobert A. Galemmo
- Brian L. WellsBWBrian L. Wells
- Karen A. RossiKRKaren A. Rossi
- Richard S. AlexanderRARichard S. Alexander
- Celia DominguezCDCelia Dominguez
- Thomas P. MaduskuieTMThomas P. Maduskuie
- Pieter F.W. StoutenPSPieter F.W. Stouten
- Matthew R. WrightMWMatthew R. Wright
- Bruce J. AungstBABruce J. Aungst
- Pancras C. WongPWPancras C. Wong
- Robert M. KnabbRKRobert M. Knabb
- Ruth R. WexlerRWRuth R. Wexler
- 1 February 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (3) , 301-304
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 1Journal of Medicinal Chemistry, 1999
- Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 2Journal of Medicinal Chemistry, 1999
- Preparation of meta-amidino-N,N-disubstituted anilines as potent inhibitors of coagulation factor XaBioorganic & Medicinal Chemistry Letters, 1998
- The de novo design and synthesis of cyclic urea inhibitors of factor Xa: Initial sar studiesBioorganic & Medicinal Chemistry Letters, 1998
- Interpretation of Thrombosis Prevention TrialThe Lancet, 1998
- Rational Design and Synthesis of Novel, Potent Bis-phenylamidine Carboxylate Factor Xa InhibitorsJournal of Medicinal Chemistry, 1998
- Bisbenzamidine isoxazoline derivatives as factor Xa inhibitorsBioorganic & Medicinal Chemistry Letters, 1997
- Efficacy and Safety of Oral Anticoagulation in Patients with CancerThrombosis and Haemostasis, 1997
- Coumadin aspirin reinfarction study: Rationale and design of the CARS studyJournal of Thrombosis and Thrombolysis, 1996
- KSG-504Drugs of the Future, 1995